ENT Devices Market : geographic growth analysis and Current industry Trends

The global ENT devices market is expected to reach USD 14,001 Million by 2020 from USD 9,595 Million in 2015, at a CAGR of 6.5% during the forecast period. Growth in ENT Devices market is mainly driven by the high prevalence of chronic sinusitis, rising geriatric population, favorable reimbursement scenario for ENT procedures in developed countries, rising adoption of minimally invasive ENT procedures, increasing presence of prominent players in the ENT devices market, and technological advancements.

The ENT devices market in this report is segmented on the basis of products, end users, and regions. Based on product, ENT Devices market is segmented into diagnostic devices, surgical devices, hearing aids, hearing implants, CO2 lasers, and image-guided surgery systems. Hearing aids are expected to account for the largest share of ENT Devices market in 2015. The hearing implants segment is slated to grow at a highest CAGR during the forecast period. The high growth in this segment is attributed to the high prevalence of hearing loss, growing geriatric population, rising number of product approvals, and technological advancements.

Request FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=150060281

The diagnostic devices market is segmented into endoscopes and hearing screening devices. In 2015, the endoscopes segment is estimated to command the largest share of the diagnostic devices market. This segment is expected to continue to dominate the market and grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing number of minimally invasive surgical procedures performed across the globe and introduction of technologically advanced products.

The surgical devices market is classified into powered surgical instruments, radiofrequency devices, handheld instruments, balloon sinus dilation devices, ENT supplies, ear tubes, and voice prosthesis devices. In 2015, the handheld instruments segment is expected to hold the largest market share and is expected to continue to dominate the surgical devices market during the forecast period.

The global ENT Devices market is dominated by North America, followed by Europe. The ENT Devices market in Asia is expected to grow at a highest CAGR during the forecast period. Factors such as growing preference for minimally invasive ENT surgeries, rise in disposable incomes in developing countries, growing geriatric population, rising incidence of hearing loss and disorders, increasing focus of market players in this region, and less-stringent regulatory guidelines in the region are expected to drive the growth of Asian ENT devices market.

Key ENT Devices market players include Medtronic plc (Ireland), Olympus Corporation (Japan), KARL STORZ GmbH & CO. KG (Germany), Stryker Corporation (U.S.), Smith & Nephew plc (U.K.), Hoya Corporation (Japan), Acclarent, Inc. (a Johnson & Johnson Company) (U.S.), Sonova Holdings AG (Switzerland), William Demant Holdings A/S (Denmark), and Cochlear Limited (Australia).

Press Release: https://www.marketsandmarkets.com/PressReleases/ent-devices.asp

Share this post:

Related Posts

Comments are closed.